BiomX Inc. Gains 43.31%
Wed, Mar 01, 2023 at 07:11 PM
BiomX Inc. (PHGE:NYSEMKT) rocketted at $0.58, a gain of 43.3%. On Wed, Mar 01, 2023, PHGE:NYSEMKT touched a New 2-Week High of $0.58. The stock appeared on our News Catalysts scanner on Wed, Feb 22, 2023 at 08:53 AM in the 'BIOTECH' category. From Wed, Feb 15, 2023, the stock recorded 44.44% Up Days and 50.00% Green Days
About BiomX Inc. (PHGE:NYSEMKT)
BiomX Inc is a clinical stage microbiome company based in Israel. The company is engaged on developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectalcancer, and primary sclerosing cholangitis.
Top 10 Gainers:
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 198.91%
- HPX Corp. Class A (HPX:NYSEMKT), 173.71%
- HPX Corp. Class A (HPX:NYSE), 173.71%
- Cardio Diagnostics Holdings Inc Com (CDIO:NASDAQ), 91.3%
- OncoSec Medical Incorporated (ONCS:NASDAQ), 88.89%
- BiomX Inc. (PHGE:NYSEMKT), 43.31%
- Decarbonization Plus Acquisition Corporation IV (DCRD:NASDAQ), 40.52%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 37.72%
- Mmtec, Inc. (MTC:NASDAQ), 37.39%
- Powerbridge Technologies Co., Ltd. (PBTS:NASDAQ), 34.43%